Darius Ebrahimi‐Fakhari

13.7k total citations
85 papers, 2.9k citations indexed

About

Darius Ebrahimi‐Fakhari is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Darius Ebrahimi‐Fakhari has authored 85 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 20 papers in Neurology. Recurrent topics in Darius Ebrahimi‐Fakhari's work include Hereditary Neurological Disorders (19 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Genetics and Neurodevelopmental Disorders (14 papers). Darius Ebrahimi‐Fakhari is often cited by papers focused on Hereditary Neurological Disorders (19 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Genetics and Neurodevelopmental Disorders (14 papers). Darius Ebrahimi‐Fakhari collaborates with scholars based in United States, Germany and United Kingdom. Darius Ebrahimi‐Fakhari's co-authors include Mustafa Şahin, Pamela J. McLean, Lara Wahlster, Afshin Saffari, Christine Klein, Vivek K. Unni, Bradley T. Hyman, Kellen D. Winden, Eliezer Masliah and Edward Rockenstein and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Darius Ebrahimi‐Fakhari

77 papers receiving 2.9k citations

Peers

Darius Ebrahimi‐Fakhari
Hyemyung Seo South Korea
Derya R. Shimshek Switzerland
Ellen Kanter United States
Natalia Ninkina United Kingdom
Fang Cai China
Guomei Tang United States
Baris Bingol United States
Hyemyung Seo South Korea
Darius Ebrahimi‐Fakhari
Citations per year, relative to Darius Ebrahimi‐Fakhari Darius Ebrahimi‐Fakhari (= 1×) peers Hyemyung Seo

Countries citing papers authored by Darius Ebrahimi‐Fakhari

Since Specialization
Citations

This map shows the geographic impact of Darius Ebrahimi‐Fakhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darius Ebrahimi‐Fakhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darius Ebrahimi‐Fakhari more than expected).

Fields of papers citing papers by Darius Ebrahimi‐Fakhari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darius Ebrahimi‐Fakhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darius Ebrahimi‐Fakhari. The network helps show where Darius Ebrahimi‐Fakhari may publish in the future.

Co-authorship network of co-authors of Darius Ebrahimi‐Fakhari

This figure shows the co-authorship network connecting the top 25 collaborators of Darius Ebrahimi‐Fakhari. A scholar is included among the top collaborators of Darius Ebrahimi‐Fakhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darius Ebrahimi‐Fakhari. Darius Ebrahimi‐Fakhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tam, Amy, et al.. (2025). Elevated Plasma Neurofilament Light Chain Levels in Children with Infantile‐Onset Ascending Hereditary Spastic Paralysis. Movement Disorders Clinical Practice. 12(11). 1947–1952.
2.
Dowling, James J., Mustafa Şahin, Darius Ebrahimi‐Fakhari, et al.. (2024). AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient. Nature Medicine. 30(7). 1882–1887. 11 indexed citations
3.
Tam, Amy, et al.. (2024). Expanding molecular and clinical spectrum of CPT1C‐associated hereditary spastic paraplegia (SPG73)—a case series. Annals of Clinical and Translational Neurology. 12(3). 648–652.
4.
Akula, Shyam K., Alissa M. D’Gama, Hyun Yong Koh, et al.. (2024). The spectrum of movement disorders in young children with ARX‐related epilepsy‐dyskinesia syndrome. Annals of Clinical and Translational Neurology. 11(6). 1643–1647.
5.
Carducci, Claudia, et al.. (2024). Autosomal Recessive Guanosine Triphosphate Cyclohydrolase I Deficiency: Redefining the Phenotypic Spectrum and Outcomes. Movement Disorders Clinical Practice. 11(9). 1072–1084.
6.
Tam, Amy, et al.. (2024). Juvenile‐onset Huntington's disease – Spectrum and evolution of presenting movement disorders. Annals of Clinical and Translational Neurology. 11(10). 2805–2810. 1 indexed citations
7.
Saffari, Afshin, Wardiya Afshar Saber, Lara Wahlster, et al.. (2024). High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia. Nature Communications. 15(1). 584–584. 9 indexed citations
8.
Ebrahimi‐Fakhari, Darius, Nathalie Dorison, Serena Galosi, et al.. (2024). Dyskinetic crisis in GNAO1-related disorders: clinical perspectives and management strategies. Frontiers in Neurology. 15. 1403815–1403815. 3 indexed citations
9.
Saffari, Afshin, M. L. ZIEGLER, Catherine Jordan, et al.. (2023). Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4‐Related Hereditary Spastic Paraplegia. Movement Disorders. 38(9). 1742–1750. 6 indexed citations
10.
Saber, Wardiya Afshar, Kellen D. Winden, Xutong Shi, et al.. (2023). ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations. Neurobiology of Disease. 190. 106386–106386. 8 indexed citations
11.
Grimmel, Mona, Darius Ebrahimi‐Fakhari, Angelika Rieß, et al.. (2022). Expansion of the phenotypic and molecular spectrum of CWF19L1 ‐related disorder. Clinical Genetics. 103(5). 566–573. 2 indexed citations
12.
Lange, Lara M., Paulina González-Latapí, Rajasumi Rajalingam, et al.. (2022). Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update. Movement Disorders. 37(5). 905–935. 58 indexed citations
13.
Ebrahimi‐Fakhari, Daniel, Marina Flotats‐Bastardas, Darius Ebrahimi‐Fakhari, et al.. (2019). Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study. Neuropediatrics. 50(5). 294–299. 5 indexed citations
14.
Winden, Kellen D., Darius Ebrahimi‐Fakhari, & Mustafa Şahin. (2018). Abnormal mTOR Activation in Autism. Annual Review of Neuroscience. 41(1). 1–23. 150 indexed citations
15.
Ebrahimi‐Fakhari, Daniel, Martin Poryo, Norbert Graf, et al.. (2018). Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet Journal of Rare Diseases. 13(1). 106–106. 87 indexed citations
16.
Ebrahimi‐Fakhari, Darius, Lara Wahlster, Jessie Zhang, et al.. (2016). Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells. Human Molecular Genetics. 25(16). 3588–3599. 74 indexed citations
17.
Ebrahimi‐Fakhari, Darius, Angelika Seitz, Stefan Kölker, & Georg F. Hoffmann. (2015). Recurrent Stroke-Like Episodes in FBXL4-Associated Early-Onset Mitochondrial Encephalomyopathy. Pediatric Neurology. 53(6). 549–550. 9 indexed citations
18.
Ebrahimi‐Fakhari, Darius, et al.. (2013). Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies. Acta Neuropathologica Communications. 1(1). 79–79. 68 indexed citations
19.
Ebrahimi‐Fakhari, Darius, Lara Wahlster, Georg F. Hoffmann, & Stefan Kölker. (2013). Emerging role of autophagy in pediatric neurodegenerative and neurometabolic diseases. Pediatric Research. 75(1-2). 217–226. 33 indexed citations
20.
Unni, Vivek K., Darius Ebrahimi‐Fakhari, Charles Vanderburg, Pamela J. McLean, & Bradley T. Hyman. (2010). Studying protein degradation pathways in vivo using a cranial window-based approach. Methods. 53(3). 194–200. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026